tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Castle Biosciences price target raised to $37 from $33 at Scotiabank

Scotiabank analyst Sung Ji Nam raised the firm’s price target on Castle Biosciences to $37 from $33 and keeps an Outperform rating on the shares post the Q4 report. The company reported another year of strong execution, including 60% year-over-year revenue growth and positive cash flow from operations, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on CSTL:

Disclaimer & DisclosureReport an Issue

1